Synaptic Plasticity in Neurodegenerative Disorders (eBook, ePUB)
Redaktion: Singh, Sangeeta; Singh, Santosh Kumar; Rai, Sachchida Nand
52,95 €
52,95 €
inkl. MwSt.
Sofort per Download lieferbar
26 °P sammeln
52,95 €
Als Download kaufen
52,95 €
inkl. MwSt.
Sofort per Download lieferbar
26 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
52,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
26 °P sammeln
Synaptic Plasticity in Neurodegenerative Disorders (eBook, ePUB)
Redaktion: Singh, Sangeeta; Singh, Santosh Kumar; Rai, Sachchida Nand
- Format: ePub
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book provides a comprehensive overview of the pivotal role of synaptic plasticity in the pathogenesis, progression, and potential treatment of different neurodegenerative disorders. It serves as a valuable resource for researchers, clinicians, and students in neuroscience, computational biology, and neurology.
- Geräte: eReader
- mit Kopierschutz
- eBook Hilfe
- Größe: 3.99MB
Andere Kunden interessierten sich auch für
- Synaptic Plasticity in Neurodegenerative Disorders (eBook, PDF)52,95 €
- Nanocarriers in Neurodegenerative Disorders (eBook, ePUB)157,95 €
- Integrating Neuroimaging, Computational Neuroscience, and Artificial Intelligence (eBook, ePUB)52,95 €
- Heart and Neurologic Disease (eBook, ePUB)221,95 €
- Intraoperative Neuromonitoring (eBook, ePUB)221,95 €
- Brain and Crime (eBook, ePUB)176,95 €
- The Human Hypothalamus (eBook, ePUB)221,95 €
-
-
-
This book provides a comprehensive overview of the pivotal role of synaptic plasticity in the pathogenesis, progression, and potential treatment of different neurodegenerative disorders. It serves as a valuable resource for researchers, clinicians, and students in neuroscience, computational biology, and neurology.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Erscheinungstermin: 24. Dezember 2024
- Englisch
- ISBN-13: 9781040224328
- Artikelnr.: 72300748
- Verlag: Taylor & Francis
- Erscheinungstermin: 24. Dezember 2024
- Englisch
- ISBN-13: 9781040224328
- Artikelnr.: 72300748
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Dr. Sangeeta Singh is an Assistant Professor in the Department of Applied Science at the Indian Institute of Informational Technology, Allahabad (IIIT A), Prayagraj, Uttar Pradesh (UP), India. Prior to joining IIIT Allahabad, she worked at the ICAR Indian Veterinary Research Institute in Izzatnagar, Bareilly (UP), India. She completed her Ph.D. in 2010. Dr. Singh's research interests include neurodegenerative disorders and regenerative medicine to promote neuronal repair and regeneration. She has received various research grants from the Science and Engineering Research Board (SERB) and the Department of Science and Technology, India. Dr. Singh has published more than 50 research articles in high-impact journals, in addition to contributing book chapters and conference proceedings. Furthermore, Dr. Singh serves as a reviewer for various reputable journals and is also a Life Member of various esteemed societies, such as the Indian Academy of Neurosciences (India), the Association of Microbiologists of India, and the Society for Biomaterials and Artificial Organs India. Dr. Santosh Kumar Singh is a Senior Scientist at the Centre of Experimental Medicine and Surgery (CEMS), Faculty of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. He earned his Ph.D. from the Botany Department (Institute of Science), BHU, in 1998. In 2003, he served as a Visiting Scientist at the Department of Photosynthesis, Institute of Physical Biology, University of South Bohemia, Czech Republic. Dr. Singh has published more than 75 research articles in high-impact and reputable journals. His research primarily focuses on Drug Discovery and Development, Microbial Biotechnology, and Nanobiotechnology. Dr. Singh is a member of the Mycological Society of India, the Society of Biological Chemists, India, and the Society for Ethnopharmacology, Kolkata, India (SFE INDIA). He has served as a resource person in the Karyashala Training Course under the Accelerate Vigyan Scheme, SERB, and DST. Notably, he was awarded the "National Award for Outstanding Efforts in Science and Technology Communication through Innovative and Traditional Methods (2021)" by the Department of Science and Technology, Ministry of Science and Technology, Government of India. In 2020-2021, he also received the Order of Academic Excellence in Publication from the Institute of Medical Sciences, Banaras Hindu University, Varanasi. Dr. Sachchida Nand Rai is a Research Associate (ICMR RA) at the Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University (BHU), Varanasi. Dr. Rai completed his Ph.D. from the Biochemistry Department (Institute of Science), BHU. Before joining BHU as a Research Associate, he held a post-doctoral fellowship at the Centre of Biotechnology, University of Allahabad, Prayagraj, India. Additionally, he serves as an editorial board member for many renowned journals and has published several research articles in journals of high repute.
Chapter 1: General Introduction to Different Neurodegenerative Diseases
Chapter 2: Chemical-Induced Parkinson's Disease Model and Associated
Therapeutic Strategies Chapter 3: Recent Advancement in the Treatment of
Parkinson's Disease Cellular Models Chapter 4: Relevance of Genetic Model
and Linked Therapeutics in Parkinson's Disease Chapter 5: Importance of
Newer 3D Organoids Model Based Therapeutic Approach in Parkinson's Disease
Chapter 6: Chemical Induced Alzheimer's Disease Model and Their Therapeutic
Significance Along with Limitations Chapter 7: Advancement in the Genetic
Model of Alzheimer's Disease Chapter 8: Organoids and Alzheimer's Disease
Chapter 9: Importance of Genetic Model in Huntington's Disease Chapter 10:
Natural Source of Drugs for Neurodegenerative Diseases Chapter 11:
Limitations of Modelling in Different Neurodegenerative Diseases Chapter
12: Significance of 3D Organoid Model in Neurodegenerative Diseases
Chapter 13: Recent Advancement in Therapeutics of Rare Neurological
Disorders Chapter 14: Bio-Informatics Based Modeling in Different
Neurodegenerative Diseases and Associated Therapeutic Strategies Chapter
15: Holistic Management of Diverse Neurodegenerative Diseases in Different
Translational Models Chapter 16: Gene Therapy, OMICS Approaches, and
Translational Neurodegenerative Models: Recent Advancements and Future
Perspectives Chapter 17: Implication and Importance of Stem Cell Therapy in
a Translational Model of Neurodegenerative Diseases
Chapter 2: Chemical-Induced Parkinson's Disease Model and Associated
Therapeutic Strategies Chapter 3: Recent Advancement in the Treatment of
Parkinson's Disease Cellular Models Chapter 4: Relevance of Genetic Model
and Linked Therapeutics in Parkinson's Disease Chapter 5: Importance of
Newer 3D Organoids Model Based Therapeutic Approach in Parkinson's Disease
Chapter 6: Chemical Induced Alzheimer's Disease Model and Their Therapeutic
Significance Along with Limitations Chapter 7: Advancement in the Genetic
Model of Alzheimer's Disease Chapter 8: Organoids and Alzheimer's Disease
Chapter 9: Importance of Genetic Model in Huntington's Disease Chapter 10:
Natural Source of Drugs for Neurodegenerative Diseases Chapter 11:
Limitations of Modelling in Different Neurodegenerative Diseases Chapter
12: Significance of 3D Organoid Model in Neurodegenerative Diseases
Chapter 13: Recent Advancement in Therapeutics of Rare Neurological
Disorders Chapter 14: Bio-Informatics Based Modeling in Different
Neurodegenerative Diseases and Associated Therapeutic Strategies Chapter
15: Holistic Management of Diverse Neurodegenerative Diseases in Different
Translational Models Chapter 16: Gene Therapy, OMICS Approaches, and
Translational Neurodegenerative Models: Recent Advancements and Future
Perspectives Chapter 17: Implication and Importance of Stem Cell Therapy in
a Translational Model of Neurodegenerative Diseases
Chapter 1: General Introduction to Different Neurodegenerative Diseases
Chapter 2: Chemical-Induced Parkinson's Disease Model and Associated
Therapeutic Strategies Chapter 3: Recent Advancement in the Treatment of
Parkinson's Disease Cellular Models Chapter 4: Relevance of Genetic Model
and Linked Therapeutics in Parkinson's Disease Chapter 5: Importance of
Newer 3D Organoids Model Based Therapeutic Approach in Parkinson's Disease
Chapter 6: Chemical Induced Alzheimer's Disease Model and Their Therapeutic
Significance Along with Limitations Chapter 7: Advancement in the Genetic
Model of Alzheimer's Disease Chapter 8: Organoids and Alzheimer's Disease
Chapter 9: Importance of Genetic Model in Huntington's Disease Chapter 10:
Natural Source of Drugs for Neurodegenerative Diseases Chapter 11:
Limitations of Modelling in Different Neurodegenerative Diseases Chapter
12: Significance of 3D Organoid Model in Neurodegenerative Diseases
Chapter 13: Recent Advancement in Therapeutics of Rare Neurological
Disorders Chapter 14: Bio-Informatics Based Modeling in Different
Neurodegenerative Diseases and Associated Therapeutic Strategies Chapter
15: Holistic Management of Diverse Neurodegenerative Diseases in Different
Translational Models Chapter 16: Gene Therapy, OMICS Approaches, and
Translational Neurodegenerative Models: Recent Advancements and Future
Perspectives Chapter 17: Implication and Importance of Stem Cell Therapy in
a Translational Model of Neurodegenerative Diseases
Chapter 2: Chemical-Induced Parkinson's Disease Model and Associated
Therapeutic Strategies Chapter 3: Recent Advancement in the Treatment of
Parkinson's Disease Cellular Models Chapter 4: Relevance of Genetic Model
and Linked Therapeutics in Parkinson's Disease Chapter 5: Importance of
Newer 3D Organoids Model Based Therapeutic Approach in Parkinson's Disease
Chapter 6: Chemical Induced Alzheimer's Disease Model and Their Therapeutic
Significance Along with Limitations Chapter 7: Advancement in the Genetic
Model of Alzheimer's Disease Chapter 8: Organoids and Alzheimer's Disease
Chapter 9: Importance of Genetic Model in Huntington's Disease Chapter 10:
Natural Source of Drugs for Neurodegenerative Diseases Chapter 11:
Limitations of Modelling in Different Neurodegenerative Diseases Chapter
12: Significance of 3D Organoid Model in Neurodegenerative Diseases
Chapter 13: Recent Advancement in Therapeutics of Rare Neurological
Disorders Chapter 14: Bio-Informatics Based Modeling in Different
Neurodegenerative Diseases and Associated Therapeutic Strategies Chapter
15: Holistic Management of Diverse Neurodegenerative Diseases in Different
Translational Models Chapter 16: Gene Therapy, OMICS Approaches, and
Translational Neurodegenerative Models: Recent Advancements and Future
Perspectives Chapter 17: Implication and Importance of Stem Cell Therapy in
a Translational Model of Neurodegenerative Diseases